tiprankstipranks
Pacific Health Care Organization (PFHO)
OTHER OTC:PFHO
US Market

Pacific Health Care Organization (PFHO) AI Stock Analysis

6 Followers

Top Page

PFHO

Pacific Health Care Organization

(OTC:PFHO)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
$1.50
▲(14.50% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by strong financial performance—especially the debt-free balance sheet and materially improved 2025 growth and margins. This is tempered by weaker near-term technical signals (below key short/intermediate moving averages with negative MACD) and only moderately positive valuation support from a ~12x P/E.
Positive Factors
Debt-free balance sheet
A zero-debt balance sheet materially reduces financial risk and interest burden, giving management flexibility to fund growth organically, make selective investments, or withstand cyclical stress without relying on external financing. This enhances long-term resilience and capital allocation optionality.
Negative Factors
Operating margin volatility
Wide swings in EBIT margin signal sensitivity to cost structure, client mix, or discrete items, which undermines predictability of core earnings. For a service business, persistent margin volatility complicates pricing and staffing decisions and can impair sustainable reinvestment and planning over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A zero-debt balance sheet materially reduces financial risk and interest burden, giving management flexibility to fund growth organically, make selective investments, or withstand cyclical stress without relying on external financing. This enhances long-term resilience and capital allocation optionality.
Read all positive factors

Pacific Health Care Organization (PFHO) vs. SPDR S&P 500 ETF (SPY)

Pacific Health Care Organization Business Overview & Revenue Model

Company Description
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third-party administrators, municipalities, and other industries in t...

Pacific Health Care Organization Financial Statement Overview

Summary
Strong overall fundamentals supported by a sharp 2025 revenue acceleration (~63%) and improved profitability (net margin ~20.7%, gross margin ~47.9%). Balance sheet strength is a major positive with no debt and growing equity, reducing financial risk. Offsetting factors include some volatility in operating margins and inconsistent free cash flow growth despite good cash conversion.
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
74
Positive
BreakdownDec 2025Dec 2024Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.72M6.07M5.63M5.74M5.40M
Gross Profit3.22M2.58M2.16M2.18M2.01M
EBITDA1.03M1.30M716.06K700.12K1.25M
Net Income1.39M883.58K767.93K492.89K995.02K
Balance Sheet
Total Assets13.48M12.43M11.82M12.05M11.33M
Cash, Cash Equivalents and Short-Term Investments12.21M11.10M10.44M10.78M10.09M
Total Debt0.0035.30K56.49K50.14K70.37K
Total Liabilities401.85K745.60K1.02M735.07K508.46K
Stockholders Equity13.07M11.69M10.80M11.32M10.82M
Cash Flow
Free Cash Flow1.14M665.95K914.84K672.37K368.01K
Operating Cash Flow1.16M675.08K932.36K711.24K386.39K
Investing Cash Flow-990.15K-1.13M806.79K-8.76M-18.38K
Financing Cash Flow-72.31K35.30K-1.21M0.00218.90K

Pacific Health Care Organization Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.31
Price Trends
50DMA
1.24
Negative
100DMA
1.23
Negative
200DMA
1.14
Positive
Market Momentum
MACD
-0.02
Positive
RSI
43.79
Neutral
STOCH
27.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PFHO, the sentiment is Neutral. The current price of 1.31 is above the 20-day moving average (MA) of 1.19, above the 50-day MA of 1.24, and above the 200-day MA of 1.14, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 43.79 is Neutral, neither overbought nor oversold. The STOCH value of 27.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PFHO.

Pacific Health Care Organization Risk Analysis

Pacific Health Care Organization disclosed 24 risk factors in its most recent earnings report. Pacific Health Care Organization reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Pacific Health Care Organization Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$15.17M11.9911.75%8.72%66.72%
61
Neutral
$3.55B-8.51-39.45%37.38%-912.18%
60
Neutral
$3.83B-88.83-0.49%47.39%85.35%
54
Neutral
$902.43M-14.21-25.73%15.23%38.79%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
$17.27B-3.03-27.74%14.92%-286.72%
49
Neutral
$7.18B18.6810.99%13.71%-18.02%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PFHO
Pacific Health Care Organization
1.19
0.47
64.58%
CNC
Centene
35.11
-26.24
-42.77%
MOH
Molina Healthcare
139.38
-201.00
-59.05%
CLOV
Clover Health Investments
1.72
-1.49
-46.42%
OSCR
Oscar Health
11.92
-0.62
-4.94%
ALHC
Alignment Healthcare
18.76
0.94
5.27%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026